CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
Hung-Yao Lin, Tai-Chung Tseng
Clin Mol Hepatol. 2022;28(2):181-182.   Published online 2022 February 21    DOI: https://doi.org/10.3350/cmh.2022.0028

Excel Download

Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
Clinical and Molecular Hepatology. 2022;28(2):181-182   Crossref logo
Link1 Link2 Link3

PGI3 Comparative Safety of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in Chronic Hepatitis B Patients
Value in Health. 2020;23:S533   Crossref logo
Link1 Link2

O-043: Safety and efficacy at 1 year after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic HBV patients with risk factors for TDF use
Journal of Viral Hepatitis. 2018;25:27-27   Crossref logo
Link1 Link2

Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B
Intervirology. 2021;65(2):94-103   Crossref logo
Link1 Link2

Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B
Life. 2021;11(3):263   Crossref logo
Link1

Tenofovir Alafenamide: A Review in Chronic Hepatitis B
Drugs. 2017;77(9):1017-1028   Crossref logo
Link1 Link2 Link3

Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study
PeerJ. 2021;9:e12527   Crossref logo
Link1 Link2 Link3 Link4

Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide
Journal of Viral Hepatitis. 2019;26(5):561-567   Crossref logo
Link1 Link2 Link3 Link4

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy
Drug Design, Development and Therapy. 2017;Volume 11:3197-3204   Crossref logo
Link1 Link2

Bone and renal safety profile at 72 weeks after switching to tenofovir alafenamide in chronic hepatitis B patients
JGH Open. 2020;5(2):258-263   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.